Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Sustainable purification of gene therapy pharmaceuticals

Reference number
Coordinator Nyctea Technologies AB
Funding from Vinnova SEK 1 000 000
Project duration August 2024 - July 2025
Status Ongoing
Venture Strategic efforts HI
Call Sustainable manufacturing of pharmaceuticals and medical technology products - spring 2024

Important results from the project

The goal of the project was to validate a new technology for the purification of pharmaceuticals. Within the framework of the project, we succeeded in demonstrating a water-based electrochemical purification process that reduces the need for chemicals and solvents. The results indicate that the desired purity and yield can be achieved. Work remains before the technology is ready for implementation; for example, further scalability needs to be demonstrated.

Expected long term effects

The project is expected to contribute in the long term to reducing the considerable costs, both economic and environmental, associated with the industrial production of modern biological medicines such as gene therapies. More efficient production could have a direct impact on the availability of advanced treatments to significantly more patients around the world, directly contributing to the UN´s global objective for good health and well-being and supports the goals for sustainable production.

Approach and implementation

The operational work was carried out mainly by Nyctea Technologies at BioVentureHub in close collaboration with AstraZeneca, who provided access to materials and infrastructure for the validation. We were able to set a clear specification of the criteria that the technology needs to achieve for industrial adoption. The project followed the schedule well and the necessary resources were available. The collaboration has worked very well, but the ambition was set high and further work remains.

External links

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 29 August 2025

Reference number 2024-01518